chr14-24308205-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_174913.3(NOP9):c.*3110A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.946 in 311,668 control chromosomes in the GnomAD database, including 139,598 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.94 ( 66800 hom., cov: 32)
Exomes 𝑓: 0.96 ( 72798 hom. )
Consequence
NOP9
NM_174913.3 3_prime_UTR
NM_174913.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.521
Publications
4 publications found
Genes affected
NOP9 (HGNC:19826): (NOP9 nucleolar protein) Enables RNA binding activity. Predicted to be involved in ribosome biogenesis. Predicted to be part of 90S preribosome and preribosome, small subunit precursor. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
CIDEB (HGNC:1977): (cell death inducing DFFA like effector b) Enables identical protein binding activity. Involved in activation of cysteine-type endopeptidase activity; positive regulation of cell death; and positive regulation of release of cytochrome c from mitochondria. Acts upstream of or within apoptotic process. Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
LTB4R2 (HGNC:19260): (leukotriene B4 receptor 2) Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in inflammatory response and neuropeptide signaling pathway. Predicted to act upstream of or within keratinocyte migration and signal transduction. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.957 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.936 AC: 142411AN: 152146Hom.: 66769 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
142411
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.955 AC: 152243AN: 159404Hom.: 72798 Cov.: 0 AF XY: 0.955 AC XY: 82381AN XY: 86276 show subpopulations
GnomAD4 exome
AF:
AC:
152243
AN:
159404
Hom.:
Cov.:
0
AF XY:
AC XY:
82381
AN XY:
86276
show subpopulations
African (AFR)
AF:
AC:
4517
AN:
5054
American (AMR)
AF:
AC:
5150
AN:
5482
Ashkenazi Jewish (ASJ)
AF:
AC:
4154
AN:
4326
East Asian (EAS)
AF:
AC:
7155
AN:
8336
South Asian (SAS)
AF:
AC:
24743
AN:
25862
European-Finnish (FIN)
AF:
AC:
6221
AN:
6386
Middle Eastern (MID)
AF:
AC:
616
AN:
634
European-Non Finnish (NFE)
AF:
AC:
91823
AN:
95104
Other (OTH)
AF:
AC:
7864
AN:
8220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
331
663
994
1326
1657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.936 AC: 142497AN: 152264Hom.: 66800 Cov.: 32 AF XY: 0.935 AC XY: 69632AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
142497
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
69632
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
36924
AN:
41524
American (AMR)
AF:
AC:
14206
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
3342
AN:
3472
East Asian (EAS)
AF:
AC:
4400
AN:
5184
South Asian (SAS)
AF:
AC:
4566
AN:
4822
European-Finnish (FIN)
AF:
AC:
10351
AN:
10616
Middle Eastern (MID)
AF:
AC:
282
AN:
294
European-Non Finnish (NFE)
AF:
AC:
65538
AN:
68024
Other (OTH)
AF:
AC:
1994
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
464
928
1393
1857
2321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3134
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.